Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment

NCT02040844 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT02040844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02040844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment
Lead sponsor
Circassia Limited
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
May 31, 2017
Enrollment
430 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cat allergy